What’s new: First reconciliation results for the CMS Innovation Center’s Enhancing Oncology Model (EOM) showed cost savings for more than three quarters of participants; more than half were also rewarded for quality of care.
Why it matters: EOM – informed by lessons learned from its predecessor, the Oncology Care Model – is showing great promise for achieving major cost savings and improved quality of care for cancer patients: of the 43 participants evaluated in the model’s first performance period, 79% achieved savings relative to historical spending and more than half earned the highest performance bonus for quality.
What to expect: In July 2025, the model welcomed its second cohort of participants who will help shape the future of cancer care; the cohort includes seven new oncology physician group practices for a combined total of 3,000 practitioners committed to value-based, patient-centered oncology care at 500 sites across 33 states and Washington, D.C.
The big picture: EOM supports the Innovation Center’s strategic priority of patient empowerment by putting the patient at the center of the care team, as well as protecting federal taxpayers by refining incentives to achieve smarter spending for high-quality care.
Additional details: EOM aims to drive transformation and improve care coordination in oncology care. Read the first annual EOM evaluation report which shows practices are investing in pharmaceutical interventions that are likely reducing Part B chemotherapy costs. For a brief overview, check out the At-a-Glance or Executive Summary. For more detail about payments, visit the Performance Period 1 reconciliation results.
Find out more: